• Skip to main content
  • Skip to primary sidebar

Eco Friendly CBD OIL

The Best Eco Friendly CBD Oil

  • Home
  • Contact
  • CBD Health
  • Cannabis News

Minor Cannabinoids: Pharmacological Effects – CBD Health and Wellness

February 17, 2021 by CBD OIL







In a recent study, the activity of eight cannabinoids and their effects on cannabinoid 1 (CB1) and CB2 receptors were evaluated.[1] The study, published in Scientific Reports, assessed the effect of certain cannabinoids on cells (in vitro) and a mouse model (in vivo).

Assays were used to screen cannabinoids against each other and a reference compound to assess their activity. The researchers found that all cannabinoids displayed some level of activity at CB1 or CB2 receptor sites in cell culture assays, in addition to different effects on behavior.

Tetrahydrocannabinolic acid (THCA)

  • Greater affinity (strength of binding) toward the CB2 receptor
  • Pain-relieving effects, as well as reduced motor activity, at lower doses (3mg/kg) and anti-anxiety effects at higher doses (10mg/kg)

Tetrahydrocannabivarin (THCV)

  • Agonist/partial agonist (increases activity) at CB1 and CB2 receptors
  • Loss of motion and hypothermia at high doses, and pain-relieving and anti-anxiety effects, as well as reduced motor activity, at both high and low doses

Cannabidiolic acid (CBDA)

  • Partial agonism at CB2 receptor
  • Notable effects on reducing anxiety and motor activity

Cannabidivarin (CBDV)

  • Affinity for the CB2 receptor
  • No significant in vivo response, though previous reports have linked this cannabinoid with anticonvulsant effects at higher doses than tested

Cannabigerol (CBG)

  • Weak partial agonist at both CB1 and CB2 receptors
  • Small effect on pain and anxiety relief at high doses

Cannabichromene (CBC)

  • Partial agonist at both CB1 and CB2 receptors with great potency at CB2 receptors
  • Small effect on pain and motor activity

The data uncovered in the study supports the growing school of thought that it’s important to understand the pharmacology of lesser-abundant cannabinoids and the receptors they interact with to fully grasp the pharmacology of cannabis-derived molecules.

Image Credit: Public Domain Pictures

Image Source: https://pixabay.com/illustrations/microbiology-cell-gene-dna-163470/

Reference

  1. Zagzoog A, et al. “In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa.” Sci Rep. 2020;10:20405.



Filed Under: CBD Health

Primary Sidebar

Dispensaries Prepare to Sell Medical Cannabis in West Virginia

Verano Holdings Enters into Agreement to Expand Arizona Footprint

Indus Holdings Inc. Announces the Acquisition of Lowell Herb Co.

Pennsylvania State Senators Team Up to Introduce Bipartisan Adult-Use Cannabis Legislation

How Texas Original Compassionate Cultivation Weathered the State’s Winter Storm

Segra Enters Agreement Making BioAgronomics Group’s Premium Cannabis Cultivar Portfolio Available to Licensed Producers Across Canada and Select International Markets

GMPs & Cannabis Manufacturing | Cannabis Industry Journal

.eco profile for cbdoil.eco